Physician profile
Charles J Fox
NPI 1477612729
$11,332.97
in general payments reported to CMS, 2019-2025
31 companies · $1,204 in 2025
The $1,204 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,201 · 2020: $369 · 2021: $502 · 2022: $941 · 2023: $3,380 · 2024: $737 · 2025: $1,204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,176 · Travel and Lodging: $2,144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,175.89 |
| Travel and Lodging | $2,144.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prytime Medical Devices, INC. | $2,883.68 | 2019 | |
| Lemaitre Vascular, INC. | $2,279.04 | 2022-2024 | Hydro Lemaitre Valvulotome, Artegraft Vascular Graft |
| W. L. Gore & Associates, INC. | $1,058.87 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Bolton Medical INC | $626.87 | 2019-2025 | Relay Thoracic Stent-Graft With Plus Delivery System, Treo Abdominal Stent-Graft System |
| Medtronic, INC. | $583.33 | 2021-2024 | Endurant Iis, Venaseal |
| Cook Medical LLC | $554.95 | 2020-2025 | Zenith, Zilver Ptx, Zenith Alpha |
| Abbott Laboratories | $498.84 | 2019-2025 | Esprit |
| Penumbra, INC. | $472.84 | 2019-2025 | Indigo System |
| Medtronic Vascular, INC. | $361.01 | 2019-2020 | |
| Boston Scientific Corporation | $331.25 | 2021-2025 | Enroute Transcarotid Neuroprotection System, Varithena Administration Pack, Angiojet Ultra 5000a |
| Silk Road Medical, INC. | $307.33 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Z-Medica, LLC | $209.18 | 2019 | |
| Smith+Nephew, INC. | $163.33 | 2021-2022 | |
| Humacyte Global, INC. | $108.08 | 2025 | Symvess |
| Organogenesis INC. | $107.98 | 2025 | Apligraf |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $105.06 | 2021-2023 | Entre Plus, Flexitouch Plus |
| Progenacare Global, LLC | $104.94 | 2023 | |
| Endologix LLC | $102.64 | 2023 | Alto Abdominal Stent Graft System |
| Becton, Dickinson and Company | $73.29 | 2025 | Venovo |
| Cordis US Corp. | $49.05 | 2021 | |
| Surmodics, INC. | $47.82 | 2023 | Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Sublime Radial Access Guide Sheath |
| Shape Memory Medical INC. | $46.40 | 2025 | Impede Embolization Plug |
| Terumo Medical Corporation | $46.14 | 2025 | Angio-Seal, Glidewire, R2p Misago |
| Edwards Lifesciences Corporation | $35.76 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Globus Medical, INC. | $35.65 | 2025 | Senza |
| Sanara Medtech INC. | $35.20 | 2022-2023 | Celleraterx |
| Acell, INC. | $27.42 | 2019 | |
| Philips North America LLC | $27.28 | 2023 | |
| Shockwave Medical, INC | $18.60 | 2021 | |
| Bioventus LLC | $17.55 | 2022 | |
| Cashflow Solutions, LLC | $13.59 | 2025 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.